GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Metropolis Healthcare Ltd (NSE:METROPOLIS) » Definitions » Current Ratio

Metropolis Healthcare (NSE:METROPOLIS) Current Ratio : 1.18 (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Metropolis Healthcare Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Metropolis Healthcare's current ratio for the quarter that ended in Mar. 2025 was 1.18.

Metropolis Healthcare has a current ratio of 1.18. It generally indicates good short-term financial strength.

The historical rank and industry rank for Metropolis Healthcare's Current Ratio or its related term are showing as below:

NSE:METROPOLIS' s Current Ratio Range Over the Past 10 Years
Min: 1.14   Med: 2.11   Max: 3.31
Current: 1.18

During the past 10 years, Metropolis Healthcare's highest Current Ratio was 3.31. The lowest was 1.14. And the median was 2.11.

NSE:METROPOLIS's Current Ratio is ranked worse than
77.98% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.15 vs NSE:METROPOLIS: 1.18

Metropolis Healthcare Current Ratio Historical Data

The historical data trend for Metropolis Healthcare's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metropolis Healthcare Current Ratio Chart

Metropolis Healthcare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.98 1.30 1.14 1.28 1.18

Metropolis Healthcare Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 - 1.64 - 1.18

Competitive Comparison of Metropolis Healthcare's Current Ratio

For the Diagnostics & Research subindustry, Metropolis Healthcare's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Metropolis Healthcare's Current Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Metropolis Healthcare's Current Ratio distribution charts can be found below:

* The bar in red indicates where Metropolis Healthcare's Current Ratio falls into.


;
;

Metropolis Healthcare Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Metropolis Healthcare's Current Ratio for the fiscal year that ended in Mar. 2025 is calculated as

Current Ratio (A: Mar. 2025 )=Total Current Assets (A: Mar. 2025 )/Total Current Liabilities (A: Mar. 2025 )
=3459.404/2943.341
=1.18

Metropolis Healthcare's Current Ratio for the quarter that ended in Mar. 2025 is calculated as

Current Ratio (Q: Mar. 2025 )=Total Current Assets (Q: Mar. 2025 )/Total Current Liabilities (Q: Mar. 2025 )
=3459.404/2943.341
=1.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Metropolis Healthcare  (NSE:METROPOLIS) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Metropolis Healthcare Current Ratio Related Terms

Thank you for viewing the detailed overview of Metropolis Healthcare's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Metropolis Healthcare Business Description

Traded in Other Exchanges
Address
Dr. Annie Besant Road, 4th Floor, East Wing, Plot-254 B, Nirlon House, Worli, Mumbai, MH, IND, 400 030
Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.

Metropolis Healthcare Headlines

No Headlines